ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Scientist, Oligonucleotide at CRISPR Therapeutics - ApplyBlast

Senior Scientist, Oligonucleotide

CRISPR Therapeutics

4 months ago

3.1 on Glassdoor

South Boston, MA

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

A Senior Oligonucleotide Scientist at CRISPR Therapeutics leads the design, synthesis, and analysis of modified oligonucleotides within the non-viral delivery technical development team. This role drives innovation in chemical modifications and scale-up processes, supporting pipelines from early discovery through clinical development while mentoring junior scientists.

Responsibilities

Lead design and execution of automated solid-phase synthesis
Develop and optimize robust purification processes
Oversee comprehensive structural elucidation using LC-MS and NMR
Drive optimization of synthetic routes for scale-up
Mentor junior chemists and maintain laboratory documentation

Skills

Qualifications

Ph.D. in Organic ChemistryPh.D. in Medicinal ChemistryICH Guidelines Knowledge

About CRISPR Therapeutics

crisprtx.com

Headquarters

Boston, Massachusetts, United States

Company Size

201-500 employees

Founded

2013

View Profile

CRISPR Therapeutics is a gene-editing company pioneering the development of transformative medicines using CRISPR/Cas9 technology to treat serious diseases. The company has a broad pipeline spanning hemoglobinopathies, immuno-oncology, autoimmune diseases, in vivo editing, and regenerative medicine, including CASGEVY™, the first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics operates across multiple clinical and preclinical programs in collaboration with partners such as Vertex Pharmaceuticals.